|
Lung Cancer Clinical Trials
2,664 recruiting studies across 28 states and 50 cities.
Find Trials by State
California
910 trials · 7 cities
Texas
831 trials · 7 cities
Florida
410 trials · 4 cities
New York
321 trials · 1 city
Maryland
289 trials · 1 city
District of Columbia
286 trials · 1 city
Arizona
221 trials · 3 cities
Tennessee
206 trials · 2 cities
Massachusetts
204 trials · 1 city
Ohio
188 trials · 2 cities
Illinois
169 trials · 1 city
Colorado
155 trials · 2 cities
Pennsylvania
139 trials · 1 city
North Carolina
136 trials · 2 cities
Washington
129 trials · 1 city
Georgia
100 trials · 1 city
Oregon
93 trials · 1 city
Missouri
68 trials · 1 city
Kentucky
66 trials · 1 city
Nebraska
66 trials · 1 city
Minnesota
65 trials · 1 city
Oklahoma
57 trials · 2 cities
Wisconsin
56 trials · 1 city
Indiana
50 trials · 1 city
Louisiana
29 trials · 1 city
New Mexico
27 trials · 1 city
Nevada
24 trials · 1 city
Virginia
21 trials · 1 city
Find Trials by City
New York, NY
321 trials
Baltimore, MD
289 trials
Washington, DC
286 trials
Houston, TX
276 trials
Long Beach, CA
268 trials
Los Angeles, CA
268 trials
Boston, MA
204 trials
Chicago, IL
169 trials
Nashville, TN
156 trials
Philadelphia, PA
139 trials
Arlington, TX
129 trials
Dallas, TX
129 trials
Fort Worth, TX
129 trials
Seattle, WA
129 trials
Miami, FL
125 trials
Tampa, FL
125 trials
San Francisco, CA
121 trials
Denver, CO
117 trials
San Jose, CA
108 trials
Atlanta, GA
100 trials
Orlando, FL
98 trials
Cleveland, OH
95 trials
San Antonio, TX
94 trials
Columbus, OH
93 trials
Portland, OR
93 trials
Mesa, AZ
92 trials
Phoenix, AZ
92 trials
Raleigh, NC
91 trials
San Diego, CA
71 trials
Kansas City, MO
68 trials
Louisville, KY
66 trials
Omaha, NE
66 trials
Minneapolis, MN
65 trials
Jacksonville, FL
62 trials
Sacramento, CA
60 trials
Austin, TX
56 trials
Milwaukee, WI
56 trials
Oklahoma City, OK
51 trials
Indianapolis, IN
50 trials
Memphis, TN
50 trials
Charlotte, NC
45 trials
Colorado Springs, CO
38 trials
Tucson, AZ
37 trials
New Orleans, LA
29 trials
Albuquerque, NM
27 trials
Las Vegas, NV
24 trials
Virginia Beach, VA
21 trials
El Paso, TX
18 trials
Fresno, CA
14 trials
Tulsa, OK
6 trials
Drugs Being Studied for Lung Cancer
carboplatin125Pembrolizumab111Pemetrexed90Cisplatin58Paclitaxel50Osimertinib42Atezolizumab41Durvalumab39Docetaxel39Nivolumab33Etoposide28Bevacizumab25Tislelizumab24Nab paclitaxel23Gemcitabine21Cemiplimab20Cetuximab19Ivonescimab13Cyclophosphamide13Lurbinectedin11Immunotherapy11Topotecan11Sintilimab11Tarlatamab10
Recently Updated Trials
- Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer PatientsPhase 1M.D. Anderson Cancer Center
- EQUAL: EGFR ctDNA QUantative Assessment for Lung Cancer Screening in Asian and Latinx PopulationsNADana-Farber Cancer Institute
- Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic AlterationsPhase 1/Phase 2AbbVie
- Testing Lutetium Lu 177 Dotatate in Patients With Somatostatin Receptor Positive Advanced Bronchial Neuroendocrine TumorsPhase 2National Cancer Institute (NCI)
- A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)Phase 1/Phase 2Phanes Therapeutics
- Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung CancerPhase 3National Cancer Institute (NCI)
- A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)Phase 3Zai Lab (Shanghai) Co., Ltd.
- Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary MetastasesPhase 1M.D. Anderson Cancer Center
- Autologous Adipose-Derived Mesenchymal Stem Cells for Chronic Traumatic Brain InjuryPhase 2Hope Biosciences LLC
- Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic AlterationsPhase 3AstraZeneca
Frequently Asked Questions
How many Lung Cancer clinical trials are currently recruiting?
There are 2,664 Lung Cancer clinical trials currently recruiting participants across the United States.
Which states have the most Lung Cancer trials?
The states with the most Lung Cancer clinical trials are California, Texas, Florida.
What phases are Lung Cancer trials in?
Lung Cancer trials span multiple phases: Not specified (637), Phase 2 (595), NA (491).
Can healthy volunteers join Lung Cancer trials?
Most Lung Cancer trials require participants to have the condition. None of the currently recruiting trials explicitly accept healthy volunteers.
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.